Meridia Factoids • Annualized worldwide sales (prior to US withdrawal): approximately $100M. • Annualized US sales (prior to withdrawal): approximately $25M. • Decline in US sales from 1998 peak to just before withdrawal: 81%. • ABT’s annualized US selling expenses prior to withdrawal: $0 (the drug wasn’t being promoted). Source: http://online.wsj.com/article/SB10001424052748704657304575540041186476012.html